New designs for cancer vaccine and artificial veto cells: An emerging palette of protein paints

Author： Tykocinski Mark   Chen Aoshuan   Huang Jui-Han   Weber Matthew   Zheng Guoxing  

Publisher： Humana Press, Inc

ISSN： 0257-277X

Source： Immunologic Research, Vol.27, Iss.2-3, 2003-06, pp. : 565-574

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer vaccine development: Protein transfer of membrane-anchored cytokines and immunostimulatory molecules

By Cimino Ashley   Palaniswami Purani   Kim Andrew   Selvaraj Periasamy  

Immunologic Research, Vol. 29, Iss. 1-3, 2004-06 ,pp. : 231-240

Humana Press, Inc

Access to resources Recommend Favorite

Calcineurin subunit B activates dendritic cells and acts as a cancer vaccine adjuvant

By Li Jing   Guo JunXia   Su ZhenYi   Hu MinLing   Liu Wei   Wei Qun  

International Immunology, Vol. 23, Iss. 5, 2011-05 ,pp. : 327-334

Oxford University Press

Access to resources Recommend Favorite

Mesenchymal Stem Cells: An Emerging Tool for Cancer Targeting and Therapy

By  

Current Stem Cell Research & Therapy, Vol. 3, Iss. 1, 2008-01 ,pp. : 32-42

Bentham Science Publishers

Access to resources Recommend Favorite

A vaccine for colorectral cancer

By O'Neill L.  

Trends in Immunology, Vol. 22, Iss. 7, 2001-07 ,pp. : 354-354

Elsevier

Access to resources Recommend Favorite

Prostate-Specific G-Protein Coupled Receptor, an Emerging Biomarker Regulating Inflammation and Prostate Cancer Invasion

By  

Current Molecular Medicine, Vol. 16, Iss. 6, 2016-07 ,pp. : 526-532

Bentham Science Publishers

Access to resources Recommend Favorite